Industry Consortium

Printer-friendly versionSend by email

CCRM’s founding industry consortium represents key sectors of the Regenerative Medicine (RM) industry – pharmaceutical, devices, reagents, tools, biomaterials and cell therapies. Despite their differences, they all have the same objective: to utilize the translational platforms developed by CCRM to enable new opportunities and to address real-life bottlenecks in their RM businesses. The industry consortium consists of large multinationals, small-medium enterprises (SME) and emerging biotechnology companies. The industry consortium provides market orientation and a ready supply of global receptors for technologies and products generated by CCRM.  

 

CCRM's Industry Consortium Members. (click logo to visit site)

MedinetBlood Centers of AmericaSteminent BiotherapueticsPCT Cell Therapy ServicesHemostemixAarteriocyteCellScale biomaterials testingMmiltenyibiotecPrimorigenNikonBioLife SolutionsSistemicLife TechnologiesSernova CorpInception LifebankAmagenTissue Regeneration Therapeutics Inc.ATCCaxcelon BIOPOLYMERS CORPBetaLogicLONZAVista GenINTERFACE BIOLOGISTICS INC (IBI)STEMCELL TECHNOLOGIESPfizer Canada IncAthersys IncTAP BiosystemsPALL CorporationCellular DynamicsEMD Millipore HomeOctane BiotechBD CanadaAgilent TechnologiesNorthern Therapeutics IncGE Healthcareapplikon Biotechology

 

Benefits of Industry Consortium Membership

 

Industry Consortium members are entitled to all of the benefits below, as well as those afforded to Associate Members.

 

1.  First opportunity to review and enter into negotiations for new intellectual property (IP)

  • IP from institutions representing >94% of Ontario's regenerative medicine activity
  • Access to state-of the-art research facilities at six research institutions and CCRM's core platforms
  • Represent industry on CCRM’s Commercialization Review Committee

 

2.  Leverage development support/funding

  • Propose and sponsor projects
  • Technical expertise
  • 90-day option on new IP
  • Exchange staff and trainees

 

3.  Discount on fee-for-service contracts

  • iPS & differentiated cell lines
  • Contract cell manufacturing, analysis and characterization
  • Custom biomaterial synthesis and characterization

 

4.  Validation of proprietary technologies

 

Associate Membership

 

This membership allows access to all of the benefits below. After one year, Associate Members have the opportunity to join the Industry Consortium. 

 

  • Participation in symposia
  • Priority access to technical training workshops
  • First opportunity to advertise/sponsor events
  • Use, validate and promote products
  • Networking and collaboration with other companies and investors
  • Access to Principal Investigators
  • Access to discounted fee-for-service offerings
  • Resource for future employees
  • Networking and collaboration opportunities within the RM community

 

 

For more information on Industry Consortium and Associate memberships, please contact Rahul Sarugaser, Director of Business Development at 647.919.8820 or rahul.sarugaser@ccrm.ca